Semisynthetic Maytansine Analogues for the Targeted Treatment of Cancer
- 10 June 2006
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 49 (14), 4392-4408
- https://doi.org/10.1021/jm060319f
Abstract
Maytansine, a highly cytotoxic natural product, failed as an anticancer agent in human clinical trials because of unacceptable systemic toxicity. The potent cell killing ability of maytansine can be used in a targeted delivery approach for the selective destruction of cancer cells. A series of new maytansinoids, bearing a disulfide or thiol substituent were synthesized. The chain length of the ester side chain and the degree of steric hindrance on the carbon atom bearing the thiol substituent were varied. Several of these maytansinoids were found to be even more potent in vitro than maytansine. The targeted delivery of these maytansinoids, using monoclonal antibodies, resulted in a high, specific killing of the targeted cells in vitro and remarkable antitumor activity in vivo.Keywords
This publication has 17 references indexed in Scilit:
- A Phase I Study of Cantuzumab Mertansine Administered as a Single Intravenous Infusion Once Weekly in Patients with Advanced Solid TumorsClinical Cancer Research, 2004
- Evidence that pinocytosis in lymphoid cells has a low capacity.The Journal of cell biology, 1986
- Maytansine inhibits nucleotide binding at the exchangeable site of tubulinBiochemical and Biophysical Research Communications, 1985
- MaytansineCancer Treatment Reviews, 1978
- Tumor inhibitors. 124. Structural requirements for antileukemic activity among the naturally occurring and semisynthetic maytansinoidsJournal of Medicinal Chemistry, 1978
- Studies of resin acids. 10. Approaches to the synthesis of podocarpic and dehydroabietic acidsThe Journal of Organic Chemistry, 1977
- Antimitotic Activity of the Potent Tumor Inhibitor MaytansineScience, 1975
- Carboxyl-terminal amino acid residue analysis of peptides. New methodJournal of the American Chemical Society, 1975
- Tumor inhibitors. 96. Novel maytansinoids. Structural interrelations and requirements for antileukemic activityJournal of the American Chemical Society, 1974
- Carbon to metal chlorine exchange. III. Mercuric chloride promoted reactions of exonorbornyl chlorideJournal of the American Chemical Society, 1972